FDA Urges Pause of J&J COVID Vaccine
April 13, 2021 – The FDA and CDC on Tuesday recommended that use of the Johnson & Johnson COVID-19 vaccine be discontinued after reports of blood clots in patients receiving the vaccine, the FDA and CDC announced on Tuesday.
In a statement, the FDA said 6.8 million doses of the J&J vaccine had been administered and the agency was investigating six reported cases of a rare and severe blood clot in patients who received the vaccine.
The CDC will convene a meeting of the Advisory Committee on Immunization Practices on Wednesday to review the cases.
“This is important to ensure that the healthcare provider community is aware of the potential for these side effects and can plan due to the one-time treatment required with this type of blood clot,” the FDA said on Twitter.
The agency is planning a press conference at 10 a.m. to further discuss the situation. Check back for more coverage.
Our sincere thanks to